No new pandemic has emerged by mid-2026 because official surveillance from the WHO and CDC shows only contained regional outbreaks, such as Bundibugyo Ebola in the Democratic Republic of the Congo and Uganda or sporadic hantavirus cases, without evidence of sustained human-to-human respiratory transmission or exponential growth exceeding epidemic thresholds. Seasonal influenza and COVID-19 activity remain low or declining across U.S. states, while zoonotic threats like avian influenza and mpox variants show limited spillover and effective containment through existing vaccines and diagnostics. Heightened global preparedness, including updated WHO pandemic agreements and CDC monitoring, further supports trader consensus that a novel pathogen is unlikely to reach pandemic scale this year.